Emily Bergsland, M.D.
- Professor of Clinical Medicine
- Division of Hematology Oncology
- Department of Medicine
- Ernest Rosenbaum, MD Endowed Chair of Medical Oncology
Education
UniversUniversity of Wisconsin, B.S., 1985, Biochemistry and Molecular Biology
University of Minnesota, M.D., 1982
Residencies
- 1989-92, Intern, Dept. of Medicine, University of California San Francisco
- 1990-92, Resident, Dept. of Medicine, University of California San Francisco
- 1992-92, Chief Resident and Assistant Chief of the Medical Service, Dept. of Medicine, University of California San Francisco
Postdoctoral Training
- 1994-1992, Research Fellow (P I: Douglas Hanahan, Ph.D.), Department of Biochemistry and Biophysics, University of California San Francisco
Biography
Dr. Emily Bergsland is currently a Professor of Clinical Medicine and holds the Ernest Rosenbaum, MD Endowed Chair of Medical Oncology. She received her medical degree from the University of Minnesota and completed an internship, residency, and chief residency in internal medicine at UCSF. She subsequently completed a fellowship in Medical Oncology and was a Molecular Medicine fellow before joining the UCSF faculty in 1998.
Dr. Bergsland has led numerous clinical studies in patients with gastrointestinal malignancies. Her current efforts are focused on clinical and translational research related to neuroendocrine tumors. At a national level, Dr. Bergsland is a member of the Neuroendocrine Tumor Task force for the National Cancer Institute and a member of the NCCN NET guidelines panel. She is also the study chair for a national study of a novel treatment for patients with carcinoid tumors performed by the ALLIANCE for Clinical Trials and funded by the National Cancer Institute.
Cancer surgeon Eric Nakakura, M.D., Ph.D. and medical oncologist Emily Bergsland, M.D. discussing carcinoid syndrome
Research & Funding
Data provided by UCSF Profiles, powered by CTSI
- UCSF Paul Calabresi K12 Career Development Program in Clinical OncologySponsor: NIHSponsor ID: K12CA260225Funding Period:Jul 2021-Jun 2026Principal Investigator
Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
- Study ID: NCT05746208Start Date: Apr 2023Estimated Completion Date: Jul 2027Condition(s): Neuroendocrine Tumor, Neuroendocrine Carcinoma, Carcinoma
- Study ID: NCT05746182Start Date: Apr 2023Estimated Completion Date: Dec 2025Condition(s): Pancreatic Neuroendocrine Neoplasm, Neoplasms, Neuroendocrine Tumor
- Study ID: NCT04665739Start Date: Sep 2021Estimated Completion Date: Jul 2024Condition(s): Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Neoplasm, Neuroendocrine Tumor
- Study ID: NCT03375320Start Date: Jul 2018Estimated Completion Date: Jan 2022Condition(s): Carcinoid Tumor, Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Low Grade Lung Neuroendocrine Neoplasm, Metastatic Thymic Neuroendocrine Neoplasm, Neuroendocrine Neoplasm
- Study ID: NCT03136055Start Date: Jun 2017Estimated Completion Date: Jun 2020Condition(s): Malignant Neuroendocrine Carcinoma (Diagnosis)
- Study ID: NCT01841736Start Date: Jun 2013Estimated Completion Date: Jan 0001Condition(s): Carcinoid Tumor, Neuroendocrine Tumor
- Study ID: NCT01824875Start Date: Apr 2013Estimated Completion Date: Jul 2023Condition(s): Gastrinoma, Glucagonoma, Insulinoma, Islet Cell Carcinoma, Pancreatic Polypeptide Tumor, Pancreatic Tumor, Somatostatinoma
- Study ID: NCT00843531Start Date: Jun 2009Estimated Completion Date: Aug 2016Condition(s): Neuroendocrine Tumor
- Study ID: NCT00390156Start Date: Aug 2006Estimated Completion Date: Jan 2011Condition(s): Solid Tumor
- Study ID: NCT00227617Start Date: Jun 2005Estimated Completion Date: Feb 2016Condition(s): Carcinoid Tumor, Islet Cell Tumor, Lung Cancer, Neoplastic Syndrome, Neuroendocrine Tumor
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 147
Data provided by UCSF Profiles, powered by CTSI
- Sada A, Foster TR, Al-Ward R, Sawani S, Charchar H, Pishdad R, Ben-Shlomo A, Dy BM, Lyden ML, Bergsland E, Jasim S, Raj N, Shank JB, Hamidi O, Hamrahian AH, Chambô JL, Srougi V, Fragoso MC, Graham PH, Habra MA, Bancos I, McKenzie TJ. The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study. Surgery. 2023 Nov 08. View in PubMed
- Mulvey CK, Paciorek A, Moon F, Steiding P, Shih B, Gubens MA, Zhang L, Bergsland EK, Cheng I. Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors. Endocr Relat Cancer. 2023 Oct 01. View in PubMed
- Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. J Clin Oncol. 2023 Nov 10; 41(32):5049-5067. View in PubMed
- Majmudar S, Graff SL, Kays M, Braz BX, Matt-Amaral L, Markham MJ, Subbiah IM, Bergsland E, Jain S. The Careers and Professional Well-Being of Women Oncologists During the COVID-19 Pandemic: Responding for Tomorrow. J Med Internet Res. 2023 08 21; 25:e47784. View in PubMed
- Varghese DG, Del Rivero J, Bergsland E. Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel). 2023 Jul 21; 15(14). View in PubMed
- View All Publications
In the News
- UCSF Surgical Oncology Program - - January 03, 2017Eric Nakakura, M.D., Ph.D., a UCSF gastrointestinal cancer surgeon and Emily Bergsland, M.D.. a UCSF gastrointestinal oncologist, recently discussed the treatment of carcinoid syndrome on "Healthy Body, Healthy Mind", a series hosted by Information Television Network (ITV), a PBS content affiliate. Dr. Nakakura is an Associate Professor in the UCSF Department of Surgery and Dr. Bergsland a Professor in the UCSF Department of Medicine. The ITV episode, which portrays the struggles of Ray Martz [...]